Healthcare

Clinical Trials / Studies

Master
Content

Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.

Content

View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.

Search for Clinical Trials

Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…
  • Cancer - All
  • Cancer - Sarcoma
Administration of HIV-specific T cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue -Auto-RESIST BMT CTN…
  • Infectious Diseases/Immune System
  • Cancer - All
  • Cancer - Lymphoma
The purpose of this study is to find the largest safe dose of TAA-specific CTLs, to learn what the side effects are, and to see whether this therapy…
  • Cancer - All
  • Cancer - Myeloma
This research study uses special immune system cells called AGAR T cells, a new experimental treatment.
  • Cancer - All
  • Cancer - Liver
  • Cancer - Sarcoma
  • Pediatrics
The purpose of this study is to find out the highest safe dose of allogeneic CD30.CAR-EBVST cells given following chemotherapy and used to treat…
  • Cancer - All
  • Cancer - Lymphoma
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
  • Cancer - Breast
  • Cancer - Head/Neck
  • Cancer - Gastric/Stomach
  • Cancer - Esophagus
  • Cancer - Colon/Rectal
  • Cancer - Bladder
  • Cancer - All
  • Cancer - Pancreas
  • Cancer - Lung
In this study, investigators attach the CD7 chimeric receptor with CD28 added to it to T cells that have had CD7 removed from their surface.
  • Cancer - All
  • Cancer - Leukemia
The primary objective of this phase 1, first in man trial is to determine the safety, toxicity, and feasibility of delivering autologous dendritic…
  • Cancer - All
  • Cancer - Pancreas
This is a Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2 or 3 prior…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Leukemia
This study is for patients who have lymphoma or leukemia that has come back or has not gone away after treatment.
  • Cancer - All
  • Cancer - Leukemia
  • Cancer - Lymphoma